MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss

Phase 4

Completed

Conditions: Obesity
Diabetes

Interventions: Behavioral: Dietary and lifestyle modification
Procedure: Adjustable gastric banding

First Posted Date: 2010-03-26

Last Posted Date: 2013-05-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 29

Registration Number: NCT01094054

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Aliskiren in Patients With Idiopathic Membranous Nephropathy

Not Applicable

Withdrawn

Conditions: Idiopathic Membranous Nephropathy

Interventions: Drug: Aliskiren

First Posted Date: 2010-03-26

Last Posted Date: 2013-03-13

Lead Sponsor: Mayo Clinic

Registration Number: NCT01093781

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome

Not Applicable

Completed

Conditions: Diarrhea
Diarrhea Predominant Irritable Bowel Syndrome

Interventions: Other: Gluten free diet
Other: Gluten rich diet

First Posted Date: 2010-03-26

Last Posted Date: 2013-05-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01094041

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Phase 4

Completed

Conditions: Inflammation
Barrett's Esophagus

Interventions: Drug: dexlansoprazole
Drug: Omeprazole

First Posted Date: 2010-03-26

Last Posted Date: 2016-03-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT01093755

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Tricuspid Regurgitation Study

Phase 4

Completed

Conditions: Right Ventricular Dysfunction
Tricuspid Regurgitation
Left Ventricular Dysfunction

Interventions: Other: Echo

First Posted Date: 2010-03-25

Last Posted Date: 2016-11-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 119

Registration Number: NCT01093001

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Electrophysiological Study of the Effects of Limb Cooling on Essential Tremor

Not Applicable

Completed

Conditions: Tremor

Interventions: Other: 15 - 30
Other: 30 - 15

First Posted Date: 2010-03-25

Last Posted Date: 2012-12-19

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT01093027

Locations: 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States

Varenicline For Smokers In Recovery From Alcohol Dependence

Phase 2

Completed

Conditions: Tobacco Abstinence

Interventions: Drug: Varenicline

First Posted Date: 2010-03-25

Last Posted Date: 2023-09-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 32

Registration Number: NCT01092702

Locations: 🇺🇸
Mayo Clinic Nicotine Research Program, Rochester, Minnesota, United States

Cervical Mobilization vs. Standard Physical Therapy for Chronic Neck Pain

Phase 2

Completed

Conditions: Neck Pain

Interventions: Procedure: Massage
Procedure: Spinal mobilization
Procedure: Neck exercises

First Posted Date: 2010-03-25

Last Posted Date: 2010-03-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 23

Registration Number: NCT01092715

Locations: 🇺🇸
Mayo Clinic Dept of Physical Medicine & Rehabilitation, Rochester, Minnesota, United States

Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Cognitive behavioral
Behavioral: Control

First Posted Date: 2010-03-23

Last Posted Date: 2012-05-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 26

Registration Number: NCT01091090

Locations: 🇺🇸
Mayo Pain Rehabilitation Center, Rochester, Minnesota, United States

A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis

Phase 1

Completed

Conditions: Primary Sclerosing Cholangitis

Interventions: Drug: Metronidazole
Drug: Vancomycin

First Posted Date: 2010-03-12

Last Posted Date: 2013-09-19

Lead Sponsor: Mayo Clinic

Target Recruit Count: 35

Registration Number: NCT01085760

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy